BamSEC and AlphaSense Join Forces
Learn More

Cyclerion Therapeutics Inc. – Material Contracts

Formerly NASDAQ: CYCN
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.32
from S-4 11 pages Korsana Biosciences, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.27
from S-4 10 pages 2. Base Salary. the Company Will Pay You an Initial Base Salary of $330,000 Per Year, Payable in Accordance With the Company’s Standard Payroll Schedule and Subject to Applicable Deductions and Withholdings. Your Base Salary Will Be Subject to Periodic Review and Potential Adjustment in the Company’s Discretion. Your Base Salary in Effect at Any Given Time Is Referred to Herein as the “Base Salary.” 3. Bonus Compensation
12/34/56
EX-10.26
from S-4 10 pages 2. Base Salary. the Company Will Pay You an Initial Base Salary of $460,000 Per Year, Payable in Accordance With the Company’s Standard Payroll Schedule and Subject to Applicable Deductions and Withholdings. Your Base Salary Will Be Subject to Periodic Review and Potential Adjustment in the Company’s Discretion. Your Base Salary in Effect at Any Given Time Is Referred to Herein as the “Base Salary.” 3. Bonus Compensation
12/34/56
EX-10.25
from S-4 10 pages 2. Base Salary. the Company Will Pay You an Initial Base Salary of $475,000 Per Year, Payable in Accordance With the Company’s Standard Payroll Schedule and Subject to Applicable Deductions and Withholdings. Your Base Salary Will Be Subject to Periodic Review and Potential Adjustment in the Company’s Discretion. Your Base Salary in Effect at Any Given Time Is Referred to Herein as the “Base Salary.” 3. Bonus Compensation
12/34/56
EX-10.24
from S-4 10 pages 1. Positions. as CEO, You Will Report to the Board, and You Shall Have All Duties, Authorities, and Responsibilities Customarily Associated With the CEO Position. This Is a Full-Time Employment Position. It Is Understood and Agreed That You Will Not Engage in Any Other Employment, Consulting or Other Business Activities (Whether Full-Time or Part-Time), Except as Expressly Authorized in Writing by the Board. Notwithstanding the Foregoing, You May Engage in Religious, Charitable and Other Community Activities So Long as Such Activities Do Not Unreasonably Interfere or Conflict With Your Obligations to the Company. 2. Compensation
12/34/56
EX-10.23
from S-4 13 pages Consulting Agreement
12/34/56
EX-10.22
from S-4 16 pages Indemnification Agreement
12/34/56
EX-10.21
from S-4 11 pages Korsana Biosciences, Inc. 2025equity Incentive Plan Stock Option Agreement [Incentive Stock Option // Nonstatutory Stock Option]
12/34/56
EX-10.20
from S-4 12 pages Korsana Biosciences, Inc. 2025 Equity Incentive Plan Restricted Stock Agreement
12/34/56
EX-10.19
from S-4 14 pages Korsana Biosciences, Inc. 2025 Equity Incentive Plan
12/34/56
EX-10.7
from 8-K 6 pages March 31, 2026 Regina Graul, PH.D. C/O *** Re: Amended and Restated Offer Letter Dear Regina
12/34/56
EX-10.6
from 8-K 23 pages Contingent Value Rights Agreement
12/34/56
EX-10.5
from 8-K 9 pages Lock-Up Agreement
12/34/56
EX-10.4
from 8-K 20 pages Registration Rights Agreement
12/34/56
EX-10.3
from 8-K 42 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 12 pages Parent Support Agreement
12/34/56
EX-10.1
from 8-K 14 pages Company Support Agreement
12/34/56
EX-10.14
from 10-K 38 pages Collaboration and Option Agreement Article 1 Definitions
12/34/56
EX-10.1
from 10-Q 27 pages Patent License Agreement Between Massachusetts Institute of Technology and Cyclerion Therapeutics, Inc. Massachusetts Institute of Technology Patent License Agreement
12/34/56
EX-10.1
from 10-Q 7 pages Consulting Agreement
12/34/56